Aeternum Health (AETN) Return on Sales (2010 - 2026)

Aeternum Health has disclosed Return on Sales across 12 years of filings, most recently posting 0.62% for Q1 2026.

• In Q1 2026, Return on Sales fell 62.0% year-over-year to 0.62%; the TTM figure through Mar 2026 stood at 0.12% (down 10.0% YoY), while the FY2025 annual figure was 0.02%, up 6.0% from the prior year.
• Return on Sales fell to 0.62% in Q1 2026, from 0.04% in the prior quarter.
• Over the last five years, Return on Sales for AETN reached as high as 0.0% in Q1 2025 and fell as low as 1.23% in Q3 2023.
• The 5-year median for Return on Sales is 0.11% (2023), against an average of 0.23%.
• The widest YoY moves for Return on Sales: up 7 bps in 2023, down 115 bps in 2023.
• A 5-year view of Return on Sales shows it stood at 0.06% in 2022, then sank by 508 bps to 0.36% in 2023, then soared by 69 bps to 0.11% in 2024, then soared by 63 bps to 0.04% in 2025, then plunged by 1365 bps to 0.62% in 2026.
• According to Business Quant data, Return on Sales over the past three periods registered 0.62%, 0.04%, and 0.17% for Q1 2026, Q4 2025, and Q3 2025 respectively.